Related Experiment Video
Updated: Aug 7, 2026

10:39
Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module
Published on: June 18, 2015
13.2K
Multidisciplinary Endocrine Tumor Board: Assessment of the Patient Experience
Matthew A Gorris1, McKenzie L Needham2, Kayla C Finnegan2
1Division of Endocrinology and Metabolism, Atrium Health Wake Forest Baptist, Winston-Salem, NC, USA.
Journal of Patient Experience
|February 7, 2024
Summary
Patients are generally satisfied when their cases are discussed at an endocrine tumor board (ETB). However, some experience anxiety, and many wish to participate in their own ETB discussions.
Area of Science:
- Oncology
- Patient Experience Research
- Healthcare Management
Background:
- Tumor boards are crucial for cancer care coordination and patient outcomes.
- Limited research exists on the patient's perspective of tumor board discussions.
Purpose of the Study:
- To investigate patient experiences with multidisciplinary endocrine tumor boards (ETBs).
- To assess patient satisfaction, anxiety levels, and desire for participation in ETB discussions.
Main Methods:
- A 15-item survey was administered to patients over 18 whose cases were discussed at an ETB.
- Data collected over 18 months from patients using an online portal.
- Descriptive statistics and Fisher's exact test were employed for analysis.
Main Results:
- 72% of patients reported their provider explained the ETB, and 77% were informed their case would be discussed.
- While 72% were satisfied with their case being discussed, 15% reported moderate to severe anxiety.
- 66% expressed interest in participating in their own ETB discussion.
Conclusions:
- Patients generally feel positive about their cases being discussed at an ETB, leading to increased treatment plan confidence.
- Patient anxiety is a factor, and a significant desire exists for patient involvement in tumor board discussions.
- Findings highlight the need to address patient concerns and explore opportunities for patient participation in multidisciplinary tumor boards.

